Literature DB >> 35211858

Percentage of Newly Proposed High-Grade Patterns Is Associated with Prognosis of Pathological T1-2N0M0 Lung Adenocarcinoma.

Yaqi Wang1, Xin Yang2, Bing Liu1, Shi Yan1, Mengfei Liu3, Xiang Li1, Shaolei Li1, Chao Lv1, Yuanyuan Ma1, Lixin Zhou2, Zhijie Song2, Wantong Xv2, Yue Yang1, Dongmei Lin4, Nan Wu5.   

Abstract

OBJECTIVE: To evaluate the prognostic value of the percentage of high-grade patterns (micropapillary, solid, and complex glands) in early-stage lung adenocarcinoma (LUAD).
METHODS: A total of 1049 patients undergoing radical surgery with pathological T1-2N0M0 LUAD were screened retrospectively, and 191 patients were involved in the final analysis. Disease-free survival (DFS) was evaluated using the Kaplan-Meier curve and Cox regression analysis. The optimal cut-off value was determined using maximally selected rank statistics.
RESULTS: The entire cohort was divided into quartile groups based on the percentage of high-grade patterns: Group 1 (≤ 30%), Group 2 (31-55%), Group 3 (56-85%), and Group 4 (≥ 86%). There were significant differences in smoking history (P = 0.041), EGFR mutations (P < 0.001), and ALK rearrangement (P = 0.010) between the four groups, but no significant differences in other clinicopathological features. Kaplan-Meier analysis showed that a higher percentage of high-grade patterns predicted worse DFS (P = 0.001), and multivariate analysis indicated that the percentage of high-grade patterns was an independent predictor (Group 2 vs. Group 1, HR = 2.136, P = 0.228; Group 3 vs. Group 1, HR = 3.355, P = 0.035; Group 4 vs. Group 1, HR = 5.147, P = 0.003, respectively). A cut-off value of 20% (P = 0.048) and 50% (P <0.001) for high-grade patterns were tested, and both revealed a significant difference in distinguishing DFS between subgroups.
CONCLUSIONS: The percentage of high-grade patterns is associated with the prognosis of early-stage invasive LUAD. A higher percentage indicates a worse prognosis.
© 2022. Society of Surgical Oncology.

Entities:  

Year:  2022        PMID: 35211858     DOI: 10.1245/s10434-022-11444-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  2 in total

1.  Long-term survival outcomes of video-assisted thoracic surgery for patients with non-small cell lung cancer.

Authors:  Wenlong Shao; Xinguo Xiong; Hanzhang Chen; Jun Liu; Weiqiang Yin; Shuben Li; Xin Xu; Xin Zhang; Jianxing He
Journal:  Chin J Cancer Res       Date:  2014-08       Impact factor: 5.087

2.  Could tumor spread through air spaces benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-institutional study.

Authors:  Donglai Chen; Xiaofan Wang; Fuquan Zhang; Ruoshuang Han; Qifeng Ding; Xuejun Xu; Jian Shu; Fei Ye; Li Shi; Yiming Mao; Yongbing Chen; Chang Chen
Journal:  Ther Adv Med Oncol       Date:  2020-12-14       Impact factor: 8.168

  2 in total
  1 in total

Review 1.  [A Review on Pathological High-risk Factors and Postoperative Adjuvant Chemotherapy in Stage IA Lung Adenocarcinoma].

Authors:  Chen Shen; Wentao Fang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-08-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.